Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1 beta in type 2 diabetes
Seth L Masters, Aisling Dunne, Shoba L Subramanian, Rebecca L Hull, Gillian M Tannahill, Fiona A Sharp, Christine Becker, Luigi Franchi, Eiji Yoshihara, Zhe Chen, Niamh Mullooly, Lisa A Mielke, James Harris, Rebecca C Coll, Kingston HG Mills, K Hun Mok, Philip Newsholme, Gabriel Nunez, Junji Yodoi, Steven E Kahn Show all
Nature Immunology | NATURE PUBLISHING GROUP | Published : 2010
Awarded by National Health and Medical Research Council
Awarded by US National Institutes of Health
We thank A. Mori for assistance with Nlrp3<SUP>-/-</SUP> mice; J. Tschopp (University of Lausanne) for Nlrp3<SUP>-/-</SUP> mice; and E. Latz (University of Bonn) for YFP-ASC BMDMs. Supported by the National Health and Medical Research Council (516783 to S.L.M.), Science Foundation Ireland (for work at Trinity College Dublin), the United States Department of Veterans Affairs (for work at the VA Puget Sound Health Care System), the US National Institutes of Health (DK-75998 to S.E.K. for work at VA Puget Sound Health Care System, and AI063331 for work at the University of Michigan) and the Crohn's and Colitis Foundation (L.F.).